|
Hi ,
In this week’s newsletter, we spotlight the innovators and breakthroughs driving synthetic biology forward. From the latest in RNA nanostructures to new bioprinting technology, the future is unfolding rapidly. Dive into the latest research about DNA’s role in tough new materials, a $12M deal transforming U.S. pharma manufacturing, and how next-gen bioplastics are reshaping sustainability. Plus, learn a little about Max Jaderberg, who will be joining us in San Jose this coming May for SynBioBeta 2025.
Enjoy the rest of your week!
|
|
|
|
|
Reserve your spot to see Max Jaderberg, Chief AI Officer at Isomorphic Labs, speak at SynBioBeta 2025!
Max is a leading innovator in integrating artificial intelligence and drug discovery, using advanced machine learning to revolutionize therapeutic development. Previously at DeepMind, Max led the Open-Ended Learning team, driving advancements in machine learning. His work pushes the boundaries of biotechnology, applying cutting-edge AI to solve complex biological challenges.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Like our Digest? |
Please feel free to share with friends,
family, and co-workers!
|
|
|
|
|
|
SynBioBeta, LLC
3559 Mount Diablo Boulevard #2, Lafayette, CA 94549
info@synbiobeta.com |
|
Sent to: _t.e.s.t_@example.com |
Unsubscribe |
SynBioBeta, 3559 Mount Diablo Boulevard #2, Lafayette, CA 94549, United States
|
|
|